Leadership

Bob Battista

MBA, FRSPH, FRCP Edinburgh

Chief Executive Officer, Co-Founder

Bob is passionate about creating systemic change in healthcare through the proper application of technology-aided processes. Bob worked extensively in the education and public health sectors over his career. Prior to Dr.Evidence, Bob served as partner in charge of technology development as Executive Vice President of TheraCom, the first leading biotech pharmacy specializing in drug distribution, patient advocacy and reimbursement services.

In 2018 he was recognized with an honorary Surgeons’ designation into the Royal College of Physicians of Edinburgh.

Bob received a BA from National Lewis University, Chicago and an MBA from Northwestern University Kellogg Graduate School of Management.

Todd Feinman

MD

Chief Medical Officer, Co-Founder

Todd is dedicated to helping develop AI-enabled technologies that will enable anyone, including patients and doctors, to use real data to make informed healthcare decisions. Todd completed his internship at Cedars-Sinai Medical Center in Los Angeles, and his residency in Internal Medicine at Huntington Memorial Hospital in Pasadena, California. Todd specialized in Hospitalist Medicine, and he helped develop the first Hospitalist programs at FHP Hospital, Queen of the Valley Hospital and Cedars-Sinai Medical Group.

Todd received a BS from UCLA and an MD from UCLA School of Medicine.

Edan Shalev

Chief Technology Officer, Co-Founder

Edan is passionate about driving the convergence of clinical data and technology to generate insights. At Dr.Evidence, Edan oversees the software engineers and architects. His prior experience ranges from developing CAD/CAM software to creating web portals for tier-one pharmaceutical companies. He has worked for a variety of corporations, including TheraCom, where he was responsible for e-commerce systems for physicians, pharmaceutical and biotech manufactures and patient communities.

Edan received his BA from California State University, Northridge.

David Dornstreich

Chief Commercial Officer

David is passionate about building and scaling healthcare technology businesses. As leader of the Business Development, Client Success, Marketing and Revenue Operations teams at Dr.Evidence, he is responsible for developing and implementing a commercial strategy to optimize growth and client experience. Prior to joining Dr.Evidence, David served as Vice President, Strategic Initiatives and Data Partnerships at Veradigm, an Allscripts company, where he focused on biopharma business development, regularly engaging with medical societies, regulatory and government agencies and academic institutions to enrich and extend data content and capabilities.

David holds a BA in Political Science from Hofstra University.

Scott Garcia

Chief Financial Officer

Scott is passionate about operational and strategic finance and focuses relentlessly on growth and innovation. He brings 15-years of related experience in high-growth organizations with attention to scale. His prior experience with small to middle-market technology companies is a driving force for the future of Dr.Evidence. He is currently responsible for the accounting, finance, FP&A and treasury functions of the company. Scott was trained in public accounting with a specialty in auditing at Holthouse Carlin & Van Trigt.

Scott received his BS in Accounting, California State University, Northridge.

Umut Eser

PhD, BS

Chief Innovation Officer

Umut is driven by a desire to “solve the unsolvable” by applying artificial intelligence and machine learning to healthcare decision-making and emerging biomedical and biotech innovation. Umut’s previous experience includes both leadership and hands-on roles developing pioneering AI and machine-learning-based platforms, innovation tools and algorithms for biomedical intelligence.

Umut received a BS in Physics from the Middle East Technical University (METU) in Ankara Turkey and a PhD in Applied Physics from Stanford University as well as completing postdoctoral work at Harvard University.